Final version published [Regulatives / Guidelines]

posted by Panks.79 – 2010-03-08 08:22 (5957 d 08:07 ago) – Posting: # 4875
Views: 27,142

Hi,

This is my first post on this forum, so kindly forgive me for any mistakes.

These guidelines are for IR products. Can this be applicable to MR product also. Can we assume that the CminSS is not required for MR product also.

Also would like to know if by anyways we can justify a steady state study that has failed at steady state for Cmin.

Thanks.

Dr. Pankaj Patil

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
323 visitors (0 registered, 323 guests [including 26 identified bots]).
Forum time: 17:29 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5